Blog
What does it mean to be a digital company in 2025?
In 2020, we have published a series of blog posts sharing our view on what it means to be a digital company and how we approach that in practice. What have we learned and how do we reflect on the previous articles in 2025?
Data Privacy in Pharmacovigilance
Data privacy and data protection are not just buzzwords; they are critical components of a robust pharmacovigilance system. This blog post explores the crucial intersection of data privacy and pharmacovigilance, examining key regulations, principles, and practical considerations.
How often should you download ICSRs from EudraVigilance?
A pragmatic look on the safety data collection, signal detection and validation in general. And do you know that with Tepsivo Safety Database, you can set up a regular and automated download of ICSRs from EudraVigilance in bulk, easily review and import them to a safety database?
Case Study: Large Generic Company Switching from Manual to Automated Literature Screening
Big pharma companies tend to be cautious. Very cautious. And naturally, this leads to challenging questions. But at Tepsivo, we welcome them—and we foster them!
Let’s take a client’s switch to automated literature screening as an example.
Let’s have a chat
Whatever you needs are, we look forward to getting in touch with you.
Feel free to drop us a message and we will contact you right away.
Tepsivo Oy | Haartmaninkatu 4, Building 14, 00290, Helsinki, Finland | VAT number FI31367614 | contact@tepsivo.com | +358 402 204 698 | Privacy policy



